Cleared Traditional

K213872 - ComPAS2 (FDA 510(k) Clearance)

Jul 2022
Decision
214d
Days
Class 2
Risk

K213872 is an FDA 510(k) clearance for the ComPAS2. This device is classified as a Spirometer, Diagnostic (Class II - Special Controls, product code BZG).

Submitted by Morgan Scientific, Inc. (Haverhill, US). The FDA issued a Cleared decision on July 15, 2022, 214 days after receiving the submission on December 13, 2021.

This device falls under the Anesthesiology FDA review panel. Regulated under 21 CFR 868.1840.

Submission Details

510(k) Number K213872 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 13, 2021
Decision Date July 15, 2022
Days to Decision 214 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF

Device Classification

Product Code BZG - Spirometer, Diagnostic
Device Class Class II - Special Controls
CFR Regulation 21 CFR 868.1840